Erratum to: Prevalence of Helicobacter pylori Infection Worldwide: A Systematic Review of Studies with National Coverage [Dig Dis Sci, (2014), 59, (1698-1709) DOI 10.1007/s10620-014-3063-0];Prevalence of Helicobacter pylori infection worldwide: A systematic review of studies with national coverage

Digestive Diseases and Sciences

Volumn 59, Issue 8, 2014, Pages 1698-1709

  Peleteiro, Bárbara ^a,b   Bastos, Ana ^b   Ferro, Ana ^b   Lunet, Nuno ^a,b  

^a University of Porto   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Epidemiology; Helicobacter pylori; Prevalence; Systematic review; Trends

Indexed keywords

IMMUNOGLOBULIN G;

ASIA; CANCER INCIDENCE; CENTRAL AMERICA; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPE; GROUPS BY AGE; HEALTH SURVEY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; METHODOLOGY; PACIFIC ISLANDS; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; REGISTER; REVIEW; SOLDIER; SOUTH AMERICA; STOMACH CANCER; SYSTEMATIC REVIEW; UREA BREATH TEST;

HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PREVALENCE;

EID: 84905570791     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-015-3779-5     Document Type: Erratum

References (61)

1. Bertuccio P, Chatenoud L, Levi F, Praud D, et al. Recent patterns in gastric cancer: a global overview. Int J Cancer. 2009;125:666-673.
2. Peleteiro B, Severo M, La Vecchia C, Lunet N. Model-based patterns in stomach cancer mortality worldwide. Eur J Cancer Prev. 2013. doi:10.1097/CEJ.0b013e328364f2b6.
3. Levi F, Lucchini F, Gonzalez JR, Fernandez E, Negri E, La Vecchia C. Monitoring falls in gastric cancer mortality in Europe. Ann Oncol . 2004;15:338-345. (Pubitemid 38262637)
4. Lunet N, Pina F, Barros H. Regional trends in Portuguese gastric cancer mortality (1984-1999). Eur J Cancer Prev. 2004;13:271-275. (Pubitemid 39096079)
5. Tovar-Guzman V, Hernandez-Giron C, Barquera S, Rodriguez-Salgado N, Lopez-Carrillo L. Epidemiologic panorama of stomach cancer mortality in Mexico. Arch Med Res. 2001;32:312-317. (Pubitemid 32611644)
6. Lau M, Le A, El-Serag HB. Noncardia gastric adenocarcinoma remains an important and deadly cancer in the United States: secular trends in incidence and survival. Am J Gastroenterol. 2006;101:2485-2492. (Pubitemid 44665242)
7. Inghelmann R, Grande E, Francisci S, Verdecchia A, et al. Regional estimates of stomach cancer burden in Italy. Tumori. 2007;93:367-373. (Pubitemid 47403452)
8. Garcia-Esquinas E, Perez-Gomez B, Pollan M, Boldo E, et al. Gastric cancer mortality trends in Spain, 1976-2005, differences by autonomous region and sex. BMC Cancer. 2009;9:346.
9. Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: Epidemiology of an unplanned triumph. Epidemiol Rev. 1986;8:1-27.
10. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, liver flukes and Helicobacter pylori. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum. 1994;61:1-241.
11. Cavaleiro-Pinto M, Peleteiro B, Lunet N, Barros H. Helicobacter pylori infection and gastric cardia cancer: systematic review and meta-analysis. Cancer Causes Control. 2011;22:375-387.
12. Peleteiro B, La Vecchia C, Lunet N. The role of Helicobacter pylori infection in the web of gastric cancer causation. Eur J Cancer Prev. 2012;21:118-125.
13. Parkin DM. International variation. Oncogene. 2004;23:6329-6340. (Pubitemid 39272833)
14. de Martel C, Ferlay J, Franceschi S, Vignat J, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012;13:607-615.
15. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase no. 10 [internet]. Lyon, France: International Agency for Research on Cancer; 2010. http://globocan.iarc.fr. Accessed September 20, 2013.
16. Olmos JA, Rios H, Higa R. Prevalence of Helicobacter pylori infection in Argentina: results of a nationwide epidemiologic study. Argentinean HP Epidemiologic Study Group. J Clin Gastroenterol. 2000;31:33-37. (Pubitemid 30430243)
17. Moujaber T, MacIntyre CR, Backhouse J, Gidding H, Quinn H, Gilbert GL. The seroepidemiology of Helicobacter pylori infection in Australia. Int J Infect Dis. 2008;12:500-504.
18. Pandeya N, Whiteman DC. Prevalence and determinants of Helicobacter pylori sero-positivity in the Australian adult community. J Gastroenterol Hepatol. 2011;26:1283-1289.
19. Ferreccio C, Rollan A, Harris PR, Serrano C, et al. Gastric cancer is related to early Helicobacter pylori infection in a high-prevalence country. Cancer Epidemiol Biomarkers Prev. 2007;16:662-667. (Pubitemid 46650566)
20. Wang X, Terry P, Yan H. Stomach cancer in 67 Chinese counties: evidence of interaction between salt consumption and Helicobacter pylori infection. Asia Pac J Clin Nutr. 2008;17:644-650.
21. Brenner H, Berg G, Frohlich M, Boeing H, Koenig W. Chronic infection with Helicobacter pylori does not provoke major systemic inflammation in healthy adults: results from a large population-based study. Atherosclerosis. 1999;147:399-403. (Pubitemid 29512272)
22. Kuepper-Nybelen J, Thefeld W, Rothenbacher D, Brenner H. Patterns of alcohol consumption and Helicobacter pylori infection: results of a population-based study from Germany among 6545 adults. Aliment Pharmacol Ther. 2005;21:57-64. (Pubitemid 40175345)
23. Gomez NA, Salvador A, Vargas PE, Zapatier JA. Alvarez J . [Seroprevalence of Helicobacter pylori among the child population of Ecuador]. Rev Gastroenterol Peru. 2004;24:230-233.
24. Rehnberg-Laiho L, Louhija J, Rautelin H, Jusufovic J, et al. Helicobacter antibodies in Finnish centenarians. J Gerontol A Biol Sci Med Sci. 1999;54:M400-403. (Pubitemid 29441774)
25. Rehnberg-Laiho L, Rautelin H, Koskela P, Sarna S, et al. Decreasing prevalence of Helicobacter antibodies in Finland, with reference to the decreasing incidence of gastric cancer. Epidemiol Infect. 2001;126:37-42. (Pubitemid 32266426)
26. Salomaa-Rasanen A, Kosunen TU, Karjalainen J, Aromaa A, et al. IgA antibodies in persisting Helicobacter pylori infection in Finnish adults. Clin Microbiol Infect. 2006;12:236-240. (Pubitemid 43379324)
27. Seiskari T, Viskari H, Kaila M, Haapala AM, Koskela P, Hyoty H. Time trends in allergic sensitisation and Helicobacter pylori prevalence in Finnish pregnant women. Int Arch Allergy Immunol. 2009;150:83-88.
28. Broutet N, Sarasqueta AM, Cantet F, Lethuaire D, Megraud F. Is there a link between the variation in gastric cancer mortality and differences in Helicobacter pylori prevalence in different regions of France? Gastroenterol Clin Biol. 1999;23:754-760. (Pubitemid 29381820)
29. Furesz J, Lakatos S, Nemeth K, Fritz P, Simon L, Kacserka K. The prevalence and incidence of Helicobacter pylori infections among young recruits during service in the Hungarian army. Helicobacter. 2004;9:77-80. (Pubitemid 38250070)
30. Lehtinen M, Ogmundsdottir HM, Bloigu A, Hakulinen T, et al. Associations between three types of maternal bacterial infection and risk of leukemia in the offspring. Am J Epidemiol. 2005;162:662-667. (Pubitemid 41437365)
31. Gdalevich M, Cohen D, Ashkenazi I, Mimouni D, Shpilberg O, Kark JD. Helicobacter pylori infection and subsequent peptic duodenal disease among young adults. Int J Epidemiol. 2000;29:592-595. (Pubitemid 30447268)
32. Kikuchi S, Yagyu K, Obata Y, Yingsong L, et al. Serum pepsinogen values and Helicobacter pylori status among control subjects of a nested case-control study in the JACC study. J Epidemiol. 2005;15:S126-133. (Pubitemid 41410094)
33. Sasazuki S, Inoue M, Iwasaki M, Otani T, et al. Effect of Helicobacter pylori infection combined with caga and pepsinogen status on gastric cancer development among Japanese men and women: A nested case-control study. Cancer Epidemiol Biomarkers Prev. 2006;15:1341-1347. (Pubitemid 44125292)
34. Kim JH, Kim HY, Kim NY, Kim SW, et al. Seroepidemiological study of Helicobacter pylori infection in asymptomatic people in South Korea. J Gastroenterol Hepatol. 2001;16:969-975. (Pubitemid 32947137)
35. Kim N, Lee SW, Cho SI, Park CG, et al. The prevalence of and risk factors for erosive oesophagitis and non-erosive reflux disease: a nationwide multicentre prospective study in Korea. Aliment Pharmacol Ther. 2008;27:173-185. (Pubitemid 350256608)
36. Shin A, Shin HR, Kang D, Park SK, Kim CS, Yoo KY. A nested case-control study of the association of Helicobacter pylori infection with gastric adenocarcinoma in Korea. Br J Cancer. 2005;92:1273-1275. (Pubitemid 40604403)
37. Yim JY, Kim N, Choi SH, Kim YS, et al. Seroprevalence of Helicobacter pylori in south Korea. Helicobacter. 2007;12:333-340. (Pubitemid 47196330)
38. Torres J, Leal-Herrera Y, Perez-Perez G, Gomez A, et al. A community-based seroepidemiologic study of Helicobacter pylori infection in Mexico. J Infect Dis. 1998;178:1089-1094. (Pubitemid 28452203)
39. Chua TS, Fock KM, Chan YH, Dhamodaran S, et al. Seroreactivity to 19.5-kDa antigen in combination with absence of seroreactivity to 35-kDa antigen is associated with an increased risk of gastric adenocarcinoma. Helicobacter. 2002;7:257-264.
40. Gasbarrini G, Pretolani S, Bonvicini F, Gatto MR, et al. A population based study of Helicobacter pylori infection in a European country: the San Marino study. Relations with gastrointestinal diseases. Gut. 1995;36:838-844.
41. Persson C, Jia Y, Pettersson H, Dillner J, Nyren O, Ye W. H. pylori seropositivity before age 40 and subsequent risk of stomach cancer: a glimpse of the true relationship? PLoS ONE. 2011;6:e17404.
42. Sorberg M, Nyren O, Granstrom M. Unexpected decrease with age of Helicobacter pylori seroprevalence among Swedish blood donors. J Clin Microbiol. 2003;41:4038-4042. (Pubitemid 37099661)
43. Ye W, Held M, Lagergren J, Engstrand L, et al. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst. 2004;96:388-396. (Pubitemid 38351300)
44. Vyse AJ, Gay NJ, Hesketh LM, Andrews NJ, et al. The burden of Helicobacter pylori infection in England and Wales. Epidemiol Infect. 2002;128:411-417. (Pubitemid 34716369)
45. Cardenas VM, Mulla ZD, Ortiz M, Graham DY. Iron deficiency and Helicobacter pylori infection in the United States. Am J Epidemiol. 2006;163:127-134. (Pubitemid 43068981)
46. Everhart JE, Kruszon-Moran D, Perez-Perez GI, Tralka TS, McQuillan G. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis. 2000;181:1359-1363. (Pubitemid 30252540)
47. Staat MA, Kruszon-Moran D, McQuillan GM, Kaslow RA. A population-based serologic survey of Helicobacter pylori infection in children and adolescents in the United States. J Infect Dis. 1996;174:1120-1123. (Pubitemid 26357482)
48. Bures J, Kopacova M, Koupil I, Seifert B, et al. Significant decrease in prevalence of Helicobacter pylori in the Czech Republic. World J Gastroenterol . 2012;18:4412-4418.
49. Bures J, Kopacova M, Koupil I, Vorisek V, et al. Epidemiology of Helicobacter pylori infection in the Czech Republic. Helicobacter. 2006;11:56-65.
50. Leja M, Cine E, Rudzite D, Vilkoite I, et al. Prevalence of Helicobacter pylori infection and atrophic gastritis in Latvia. Eur J Gastroenterol Hepatol. 2012;24:1410-1417.
51. Lim SH, Kwon JW, Kim N, Kim GH, et al. Prevalence and risk factors of Helicobacter pylori infection in Korea: nationwide multicenter study over 13 years. BMC Gastroenterol. 2013;13:104.
52. Naja F, Nasreddine L, Hwalla N, Moghames P, et al. Association of H. pylori infection with insulin resistance and metabolic syndrome among Lebanese adults. Helicobacter. 2012;17:444-451.
53. den Hoed CM, Vila AJ, Holster IL, Perez-Perez GI, et al. Helicobacter pylori and the birth cohort effect: evidence for stabilized colonization rates in childhood. Helicobacter. 2011;16:405-409.
54. Carmack SW, Genta RM. Helicobacter pylori seroprevalence in symptomatic veterans: a study of 7310 patients over 11 years. Helicobacter. 2009;14:298-302.
55. Howden CW, Hunt RH. Guidelines for the management of Helicobacter pylori infection. Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology. Am J Gastroenterol. 1998;93:2330-2338.
56. Lam SK, Talley NJ. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol. 1998;13:1-12. (Pubitemid 28137751)
57. Malfertheiner P, Megraud F, O'Morain C, Bell D, et al. Current European concepts in the management of Helicobacter pylori infection-the Maastricht Consensus Report. The European Helicobacter pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol. 1997;9:1-2. (Pubitemid 27047348)
58. Lansdorp-Vogelaar I, Sharp L. Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention. Best Pract Res Clin Gastroenterol. 2013;27:933-947.
59. Bastos J, Carreira H, La Vecchia C, Lunet N. Childcare attendance and Helicobacter pylori infection: systematic review and meta-analysis. Eur J Cancer Prev. 2013;22:311-319.
60. Chak E, Rutherford GW, Steinmaus C. The role of breast-feeding in the prevention of Helicobacter pylori infection: a systematic review. Clin Infect Dis. 2009;48:430-437.
61. Peleteiro B, Lunet N, Barros R, La Vecchia C, Barros H. Factors contributing to the underestimation of Helicobacter pylori-associated gastric cancer risk in a high-prevalence population. Cancer Causes Control. 2010;21:1257-1264. a Tecnologia Tecnologia